All news

Lucy Haslam repulsed by medicinal cannabis laws, calls on nation to Dan's Law

It is time to fight for medicinal cannabis again

Canadian MPs join push to remove federal tax from prescribed cannabis

Conservative MP Marilyn Gladu, Liberal MP Nathaniel Erskine-Smith and NDP MP Don Davies joined CFAMM in calling for the change

Desperate patients turn to black market for medicinal cannabis despite spike in legal prescriptions

It was the day Michael Lambert watched his infant daughter suffer a violent two-and-a-half-hour seizure that he says he decided breaking the law was a small price to pay for her life

Canopy Growth appoints Dr. Danial Schecter as Director, Global Medical Services

Dr. Schecter is widely recognized as an expert in the clinical use of medical cannabis and will use his experience to expand the Company's network of partner healthcare clinics and support doctors and patients who understand the value of cannabis as medicine

Lucy Haslam repulsed by medicinal cannabis laws, calls on nation to #FixDansLaw

In a one-on-one interview with the Leader, Lucy Haslam reveals the pain this Sunday will bring, marking four years since her son's death and why she's retracting claims of victory on medicinal cannabis

Aurora Cannabis shuffles its board of directors

In the recent second quarter, Aurora slipped to a loss from a profit last year, due to higher costs and expenses, arising from the purchase of various cannabis-selling companies

How many Australians are accessing unapproved medicinal cannabis?

The number of special access approvals has shot up by hundreds over the past few months

The takeaway from cannabis in Davos: everyone thinks the ship has sailed

The cannabis industry, both in the U.S. and globally, is in a bit of a transition right now. The unprecedented momentum of 2018 has investors more bullish than ever on the future of the industry, thanks in part to new legislation and major investments from established industries

Cannabinoids: a new approach for pain control?

There is a gap between the day-to-day practice and the so-called evidence-based medicine. To impose double standards in terms of medical practice is no longer acceptable

Medical oncologists’ views on the utility of medical cannabis across the cancer trajectory

In this nationally representative sample of US oncologists, 83% reported medical cannabis to be potentially beneficial near the end of life. In contrast, only a minority reported it to be beneficial during early stage cancer (33%) or cancer survivorship (26%)